The authors found that Siglec-7 and Siglec-9 were associated with poor prognosis in prostate cancer patients, and are highly expressed in myeloid cells, including macrophages, in prostate tumor tissues.
[Journal of Clinical Investigation]
Home Newsletters Sialylated Glycoproteins Suppress Immune Cell Killing by Binding to Siglec-7 and Siglec-9...
